Apollo Endosurgery Investor Relations Material
Latest events
Q3 2022
Apollo Endosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Apollo Endosurgery Inc
Access all reports
Apollo Endosurgery, Inc. designs, develops, and markets minimally invasive medical devices for gastrointestinal and bariatric procedures. Its product portfolio includes endoscopic suturing systems and devices used in weight loss therapy and the treatment of gastrointestinal complications. Apollo Endosurgery, Inc. is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
APEN
Country
🇺🇸 United States